¼¼°èÀÇ ¿¹¹æ ÇコÄÉ¾î ±â¼ú ¹× ¼­ºñ½º ½ÃÀå
Preventive Healthcare Technologies and Services
»óǰÄÚµå : 1784049
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 185 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,183,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,550,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¿¹¹æ ÇコÄÉ¾î ±â¼ú ¹× ¼­ºñ½º ¼¼°è ½ÃÀåÀº 2030³â±îÁö 5¾ï 2,110¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 2¾ï 9,790¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¿¹¹æ ÇコÄÉ¾î ±â¼ú ¹× ¼­ºñ½º ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 9.8%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 5¾ï 2,110¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Á¶±â ¹ß°ß ¹× ½ºÅ©¸®´× ±â¼úÀº CAGR 8.8%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 1¾ï 9,970¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¸¸¼ºÁúȯ °ü¸® ±â¼ú ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 8.9%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 8,120¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 13.2%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¿¹¹æ ÇコÄÉ¾î ±â¼ú ¹× ¼­ºñ½º ½ÃÀåÀº 2024³â¿¡ 8,120¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 1¾ï 520¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 13.2%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 7.1%¿Í 8.5%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 7.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è ¿¹¹æ ÀÇ·á ±â¼ú ¹× ¼­ºñ½º ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

¿¹¹æ ÀÇ·á°¡ Àü ¼¼°è ÀÇ·á »ê¾÷¿¡¼­ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

¿¹¹æ ÀÇ·á ±â¼ú ¹× ¼­ºñ½º´Â ÀÇ·á ½Ã½ºÅÛÀÌ Áúº´ ºÎ´ãÀ» ÁÙÀ̰í, ȯÀÚ °á°ú¸¦ °³¼±Çϰí, ÀÇ·á ºñ¿ëÀ» Àý°¨Çϱâ À§ÇØ ¿¹¹æÀû Á¶Ä¡·Î ÀüȯÇÔ¿¡ µû¶ó Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. Áúº´ Ä¡·á¿¡ ÁßÁ¡À» µÐ ¼Ò±ØÀû ÇコÄÉ¾î ¸ðµ¨°ú ´Þ¸® ¿¹¹æÀû ÇコÄɾî´Â ´ç´¢º´, ½ÉÇ÷°üÁúȯ, ¾Ï µî ¸¸¼ºÁúȯÀ» ¿¹¹æÇϱâ À§ÇØ Á¶±â Áø´Ü, À§Çè Æò°¡, »ýȰ½À°ü °³¼±¿¡ ÁßÁ¡À» µÓ´Ï´Ù. »ýȰ½À°üº´ÀÌ Á¡Á¡ ´õ ¸¸¿¬ÇØÁö¸é¼­ Á¤ºÎ, º¸Çè»ç, ÀÇ·á ¼­ºñ½º Á¦°øÀÚ´Â ¿¹¹æÁ¢Á¾ ÇÁ·Î±×·¥, Á¶±â °ËÁø µµ±¸, ¸ÂÃãÇü °Ç°­ ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç µî ¿¹¹æ Àü·«À» ¿ì¼±¼øÀ§¿¡ µÎ°í ÀÖ½À´Ï´Ù. µðÁöÅÐ Çコ Ç÷§Æû, ¿þ¾î·¯ºí ±â±â, ÀΰøÁö´É ±â¹Ý Áø´ÜÀÇ µîÀåÀº ¿¹¹æ ÀÇ·á¿¡ ´ëÇÑ Á¢±Ù¼º°ú Á¤È®¼ºÀ» ´õ¿í ³ôÀ̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼ÒºñÀÚµéÀÇ °Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ À£ºùÀ» Áß½ÃÇϰí, ±â¼úÀ» Ȱ¿ëÇÏ¿© °Ç°­ »óŸ¦ ÃßÀûÇÏ°í °ü¸®Çϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. °ø°ø ¹× ¹Î°£ ÀÇ·á ºÎ¹®ÀÌ ¿¹¹æ Á¶Ä¡¿¡ ´ëÇÑ ÅõÀÚ¸¦ Áö¼ÓÇϸ鼭 ¿¹¹æ ÀÇ·á ±â¼ú ¹× ¼­ºñ½º ¼¼°è ½ÃÀåÀÌ È®´ëµÇ°í ÀÇ·á ¼­ºñ½º Á¦°øÀÇ ¹Ì·¡¸¦ À籸¼ºÇÒ °ÍÀÔ´Ï´Ù.

¿¹¹æÀû ÇコÄɾîÀÇ ¼ºÀåÀ» °¡·Î¸·´Â °úÁ¦´Â ¹«¾ùÀϱî?

ÀÌ·¯ÇÑ ÀåÁ¡¿¡µµ ºÒ±¸Çϰí, ¿¹¹æ ÀÇ·á ±â¼úÀÇ º¸±ÞÀº ¿©·¯ °¡Áö µµÀü¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ÁÖ¿ä À庮 Áß Çϳª´Â ÷´Ü Áø´Ü µµ±¸¿Í °Ç°­ °ËÁø ¼­ºñ½º¿¡ µå´Â ºñ¿ëÀ̸ç, ƯÈ÷ Àú¼ÒµæÃþÀÇ °æ¿ì ¸ðµç »ç¶÷ÀÌ °¨´çÇÒ ¼ö ÀÖ´Â ±Ý¾×ÀÌ ¾Æ´Ò ¼ö ÀÖ½À´Ï´Ù. ¿¹¹æ ÀÇ·á¿¡ ´ëÇÑ Ç¥ÁØÈ­µÈ Á¤Ã¥À̳ª »óȯ ±¸Á¶°¡ ¾ø±â ¶§¹®¿¡ º¸Çè Á¦°øÀÚ´Â ¿¹¹æº¸´Ù Ä¡·á¸¦ ¿ì¼±½ÃÇÏ´Â °æ¿ì°¡ ¸¹¾Æ ¿¹¹æ ÀÇ·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ ´õ¿í Á¦Çѵ˴ϴÙ. ¶ÇÇÑ, ¸¹Àº ȯÀÚµéÀÌ °ËÁøÀ» ¹Ì·ç°Å³ª Ãʱâ Áõ»óÀ» ¹«½ÃÇϰųª Á¤±âÀûÀÎ °Ç°­°ËÁøÀ» ¹ÞÁö ¾Ê´Â °æ¿ì°¡ ¸¹¾Æ ȯÀÚÀÇ ¿¹¹æÀû °Ç°­°ü¸® ´ëÃ¥¿¡ ´ëÇÑ ¼øÀÀµµ°¡ ¿©ÀüÈ÷ ¿ì·ÁµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀüÀڰǰ­±â·Ï(EHR), µðÁöÅÐ ÇコÄÉ¾î ±â±â, AI ±â¹Ý ºÐ¼® °£ÀÇ »óÈ£¿î¿ë¼º ¹®Á¦¸¦ ÇØ°áÇØ¾ß Çϱ⠶§¹®¿¡ ¿©·¯ Ç÷§Æû °£ ¿¹¹æÀû ÇコÄÉ¾î µ¥ÀÌÅÍ ÅëÇÕÀÇ º¹À⼺ ¶ÇÇÑ ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿¡°Ô µµÀüÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¹é½Å, ¿¹¹æ¾à, µðÁöÅÐ Çコ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ À߸øµÈ Á¤º¸¿Í ȸÀÇÀûÀÎ ½Ã°¢ÀÌ ½ÃÀå ħÅõ¸¦ Áö¿¬½Ãų °¡´É¼ºµµ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϱâ À§Çؼ­´Â Á¤ºÎÀÇ Áö¿ø °­È­, ´ëÁßÀÇ ÀÎ½Ä °³¼± Ä·ÆäÀÎ, ±â¼ú Á¦°ø¾÷ü¿Í ÀÇ·á±â°üÀÇ Àü·«Àû Çù·ÂÀÌ ÇÊ¿äÇÕ´Ï´Ù.

±â¼ú ¹ßÀüÀº ¿¹¹æ ÀǷḦ ¾î¶»°Ô °­È­ÇÒ °ÍÀΰ¡?

±â¼ú Çõ½ÅÀº ¿¹¹æÀû ÇコÄɾî Çõ¸íÀÇ ÃÖÀü¼±¿¡ ÀÖÀ¸¸ç, º¸´Ù Á¤È®Çϰí È¿À²ÀûÀÌ¸ç °³ÀÎÈ­µÈ °Ç°­ °³ÀÔÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀΰøÁö´É°ú ºòµ¥ÀÌÅÍ ºÐ¼®ÀÇ ÅëÇÕÀº Áúº´ ¿¹Ãø ¸ðµ¨À» °³¼±ÇÏ¿© ÀÇ·á Àü¹®°¡°¡ °íÀ§Ç豺À» ½Äº°Çϰí Á¶±â °³ÀÔ Àü·«À» ½ÇÇàÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí Çコ Æ®·¡Ä¿¿Í ½º¸¶Æ® ÀÇ·á±â±â¸¦ ÅëÇØ ¼ÒºñÀÚµéÀº ½É¹Ú¼ö, Ç÷¾Ð, Ç÷´ç ¼öÄ¡ µî ÁÖ¿ä °Ç°­ ÁöÇ¥¸¦ ¸ð´ÏÅ͸µÇϰí, ¿¹¹æ ÀǷḦ À§ÇÑ ½Ç½Ã°£ Çǵå¹éÀ» Á¦°ø¹ÞÀ» ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¿ø°ÝÀÇ·á ¹× µðÁöÅÐ Çコ Ç÷§ÆûÀº ¿ø°ÝÁø·á, µðÁöÅÐ °Ç°­ ÄÚĪ, AI ±â¹Ý Áø´ÜÀ» ÃËÁøÇÏ¿© ¿¹¹æ ¼­ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» ´õ¿í È®´ëÇϰí ÀÖ½À´Ï´Ù. À¯Àüü ÀÇ·á¿Í ¿¹Ãø ¹ÙÀÌ¿À¸¶Ä¿ ºÐ¼®Àº À¯ÀüÀû ¼ÒÀÎÀ» ÆÄ¾ÇÇÏ¿© ¸ÂÃãÇü ¿¹¹æ Àü·«À» °¡´ÉÇϰÔÇÔÀ¸·Î½á ¸ÂÃãÇü ÇコÄɾ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºí·ÏüÀÎ ±â¼úÀº ¾ÈÀüÇÑ ÀÇ·á µ¥ÀÌÅÍ °øÀ¯¸¦ À§ÇØ °ËÅäµÇ°í ÀÖÀ¸¸ç, ȯÀÚÀÇ ÇÁ¶óÀ̹ö½Ã¸¦ º¸ÀåÇϸ鼭 µ¥ÀÌÅÍ Áß½ÉÀÇ ¿¹¹æÀû ÇコÄÉ¾î ¼Ö·ç¼ÇÀ» °³¼±Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀÌ °è¼Ó ¹ßÀüÇÔ¿¡ µû¶ó ¿¹¹æ ÀÇ·á´Â ´õ¿í È¿°úÀûÀÌ°í ºñ¿ë È¿À²ÀûÀ̸ç Àü ¼¼°è »ç¶÷µéÀÌ ³Î¸® ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô µÉ °ÍÀÔ´Ï´Ù.

¿¹¹æÀû ÇコÄÉ¾î ±â¼ú ¹× ¼­ºñ½º ½ÃÀåÀÇ ¼ºÀå µ¿·ÂÀº?

¿¹¹æ ÀÇ·á ±â¼ú ¹× ¼­ºñ½º ½ÃÀåÀÇ ¼ºÀåÀº ¸¸¼ºÁúȯ ¿¹¹æ¿¡ ´ëÇÑ ÀνÄÀÇ Áõ°¡, Áø´Ü ±â¼úÀÇ ¹ßÀü, µðÁöÅÐ Çコ ¼Ö·ç¼ÇÀÇ È®´ë µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí Çコ ±â¼ú°ú AI¸¦ Ȱ¿ëÇÑ ¿¹Ãø ºÐ¼®ÀÇ µµÀÔÀÌ Áõ°¡Çϸ鼭 ¸ÂÃãÇü ¿¹¹æ ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä°¡ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. Áúº´ÀÇ Á¶±â ¹ß°ß°ú ¹é½Å Á¢Á¾ ÇÁ·Î±×·¥À» ÃßÁøÇÏ´Â Á¤ºÎ Á¤Ã¥Àº ƯÈ÷ ÀÇ·á ÀÎÇÁ¶ó°¡ Àß °®ÃçÁø ¼±Áø Áö¿ª¿¡¼­ÀÇ ½ÃÀå È®´ë¸¦ ´õ¿í ºÎÃß±â°í ÀÖ½À´Ï´Ù. ±â¾÷ ºÎ¹®µµ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç, °í¿ëÁÖµéÀº Á÷¿øµéÀÇ °Ç°­°ú »ý»ê¼ºÀ» ³ôÀ̱â À§ÇØ À£´Ï½º ÇÁ·Î±×·¥°ú ¿¹¹æ °ËÁø¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿¹¹æ ÀÇ·á Àü·«¿¡ ¿ø°ÝÀÇ·á ¼­ºñ½º¸¦ ÅëÇÕÇÔÀ¸·Î½á, ƯÈ÷ ¿ø°ÝÁö¿¡¼­ ¼­ºñ½º¸¦ ÃæºÐÈ÷ ¹ÞÁö ¸øÇÏ´Â »ç¶÷µéÀ» À§ÇÑ Á¢±Ù¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀÚ, º¸Çè»ç ¹× ¼ÒºñÀÚ°¡ ¿¹¹æ ÀÇ·áÀÇ Àå±âÀûÀÎ ÀÌÁ¡À» °è¼Ó ÀνÄÇÔ¿¡ µû¶ó ÀÌ ½ÃÀåÀº Áö¼ÓÀûÀ¸·Î ¼ºÀåÇÏ¿© Àü ¼¼°èÀûÀ¸·Î °Ç°­ ¹× À£´Ï½º °ü¸® ¹æ½ÄÀ» º¯È­½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÎ¹®

À¯Çüº°(Á¶±â ¹ß°ß ¹× ½ºÅ©¸®´× ±â¼ú, ¸¸¼ºÁúȯ °ü¸® ±â¼ú, ¹é½Å, ±âŸ À¯Çü)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå°ú °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ÀÇ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹üÀ» µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡°¡ ¼±º°ÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Preventive Healthcare Technologies and Services Market to Reach US$521.1 Million by 2030

The global market for Preventive Healthcare Technologies and Services estimated at US$297.9 Million in the year 2024, is expected to reach US$521.1 Million by 2030, growing at a CAGR of 9.8% over the analysis period 2024-2030. Early Detection & Screening Technologies, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$199.7 Million by the end of the analysis period. Growth in the Chronic Disease Management Technologies segment is estimated at 8.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$81.2 Million While China is Forecast to Grow at 13.2% CAGR

The Preventive Healthcare Technologies and Services market in the U.S. is estimated at US$81.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$105.2 Million by the year 2030 trailing a CAGR of 13.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.1% and 8.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.6% CAGR.

Global Preventive Healthcare Technologies and Services Market - Key Trends & Drivers Summarized

Why Is Preventive Healthcare Gaining Momentum in the Global Medical Industry?

Preventive healthcare technologies and services have witnessed substantial growth as healthcare systems shift toward proactive measures to reduce disease burden, improve patient outcomes, and lower medical costs. Unlike reactive healthcare models that focus on treating illnesses, preventive healthcare emphasizes early diagnosis, risk assessment, and lifestyle modifications to prevent chronic diseases such as diabetes, cardiovascular disorders, and cancer. With the increasing prevalence of lifestyle-related diseases, governments, insurers, and healthcare providers are prioritizing preventive strategies, including vaccination programs, early screening tools, and personalized health monitoring solutions. The rise of digital health platforms, wearable devices, and artificial intelligence-driven diagnostics has further enhanced the accessibility and accuracy of preventive healthcare. Consumers are also becoming more health-conscious, adopting wellness-focused behaviors and leveraging technology to track and manage their health. As public and private healthcare sectors continue investing in preventive measures, the global market for preventive healthcare technologies and services is set to expand, reshaping the future of healthcare delivery.

What Challenges Are Hindering the Growth of Preventive Healthcare?

Despite its advantages, the widespread adoption of preventive healthcare technologies faces multiple challenges. One of the primary barriers is the cost of advanced diagnostic tools and health screening services, which may not be affordable for all populations, particularly in low-income regions. The lack of standardized policies and reimbursement structures for preventive healthcare further limits its accessibility, as insurance providers often prioritize treatment over prevention. Additionally, patient adherence to preventive healthcare measures remains a concern, as many individuals delay screenings, ignore early symptoms, or fail to maintain regular health check-ups. The complexity of integrating preventive healthcare data across multiple platforms also presents challenges for healthcare providers, as interoperability issues between electronic health records (EHRs), digital health devices, and AI-driven analytics must be addressed. Moreover, misinformation and skepticism surrounding vaccines, preventive medications, and digital health monitoring can slow market penetration. Addressing these challenges requires increased government support, public awareness campaigns, and strategic collaborations between technology providers and healthcare institutions.

How Are Technological Advancements Enhancing Preventive Healthcare?

Technological innovation is at the forefront of the preventive healthcare revolution, enabling more precise, efficient, and personalized health interventions. The integration of artificial intelligence and big data analytics is improving disease prediction models, allowing healthcare professionals to identify high-risk individuals and implement early intervention strategies. Wearable health trackers and smart medical devices are empowering consumers to monitor key health metrics such as heart rate, blood pressure, and glucose levels, providing real-time feedback for preventive care. Telemedicine and digital health platforms are further expanding access to preventive services by facilitating remote consultations, digital health coaching, and AI-driven diagnostics. Genomic medicine and predictive biomarker analysis are revolutionizing personalized healthcare by identifying genetic predispositions to diseases, enabling tailored prevention strategies. Additionally, blockchain technology is being explored for secure health data sharing, ensuring patient privacy while improving data-driven preventive healthcare solutions. As these technologies continue to evolve, preventive healthcare will become more effective, cost-efficient, and widely accessible across global populations.

What Is Driving the Growth of the Preventive Healthcare Technologies and Services Market?

The growth in the preventive healthcare technologies and services market is driven by several factors, including increasing awareness of chronic disease prevention, advancements in diagnostic technologies, and the expansion of digital health solutions. The rising adoption of wearable health technology and AI-powered predictive analytics is accelerating the demand for personalized preventive care. Government policies promoting early disease detection and vaccination programs are further supporting market expansion, particularly in developed regions with strong healthcare infrastructure. The corporate sector is also contributing to growth, with employers investing in wellness programs and preventive screenings to enhance workforce health and productivity. Additionally, the integration of telehealth services into preventive care strategies is improving accessibility, particularly for remote and underserved populations. As healthcare providers, insurers, and consumers continue to recognize the long-term benefits of preventive healthcare, the market is expected to witness sustained growth, transforming the way health and wellness are managed globally.

SCOPE OF STUDY:

The report analyzes the Preventive Healthcare Technologies and Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines, Other Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â